Literature DB >> 15998815

Epidemiology of gastric cancer in Japan.

M Inoue1, S Tsugane.   

Abstract

Despite its decreasing trend in Japan, gastric cancer remains an important public health problem. Although the age standardised rates of gastric cancer have been declining for decades, the absolute numbers are increasing because of the rapid aging of the population. A large proportion of Japanese gastric cancers are detected at an early stage, with a better overall survival rate. As with Western developed countries, a change in the social environment such as reduced salt use and increased fresh vegetable and fruit intake as well as improvement of food storage may play an important part in the decline. Differences in Helicobacter pylori infection rates between generations presumably have contributed to the generation related variation in the declining trends. It is expected that most gastric cancers in Japan may be preventable by lifestyle modification such as salt reduction and increased fruit and vegetable intake, together with avoidance of smoking and countermeasures against H pylori infection so that the level now evident in Western developed countries can be reached.

Entities:  

Mesh:

Year:  2005        PMID: 15998815      PMCID: PMC1743301          DOI: 10.1136/pgmj.2004.029330

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  15 in total

1.  Screening for gastric cancer in Japan.

Authors:  Yoshitaka Tsubono; Shigeru Hisamichi
Journal:  Gastric Cancer       Date:  2000-08-04       Impact factor: 7.370

2.  Early carcinoma of the gastric cardia in Japan: is it different from that in the West?

Authors:  T Okabayashi; T Gotoda; H Kondo; T Inui; H Ono; D Saito; S Yoshida; M Sasako; T Shimoda
Journal:  Cancer       Date:  2000-12-15       Impact factor: 6.860

3.  Is gastric carcinoma different between Japan and the United States?

Authors:  Y Noguchi; T Yoshikawa; A Tsuburaya; H Motohashi; M S Karpeh; M F Brennan
Journal:  Cancer       Date:  2000-12-01       Impact factor: 6.860

4.  Clinicopathological study of gastric carcinoma in high- and low-mortality countries: Comparison between Japan and the United States.

Authors:  Michio Maruyama; Kimiya Takeshita; Mitsuo Endo; Mark Deakin; AR Moossa
Journal:  Gastric Cancer       Date:  1998-12       Impact factor: 7.370

Review 5.  H. pylori and gastric cancer: the Asian enigma.

Authors:  Hiroto Miwa; Mae F Go; Nobuhiro Sato
Journal:  Am J Gastroenterol       Date:  2002-05       Impact factor: 10.864

6.  Natural history of early gastric cancer: a non-concurrent, long term, follow up study.

Authors:  H Tsukuma; A Oshima; H Narahara; T Morii
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

7.  Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population.

Authors:  M Asaka; T Kimura; M Kudo; H Takeda; S Mitani; T Miyazaki; K Miki; D Y Graham
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

8.  Helicobacter pylori infection and chronic atrophic gastritis among Japanese blood donors: a cross-sectional study.

Authors:  A Fukao; S Komatsu; Y Tsubono; S Hisamichi; H Ohori; T Kizawa; N Ohsato; N Fujino; N Endo; M Iha
Journal:  Cancer Causes Control       Date:  1993-07       Impact factor: 2.506

9.  Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. The EUROGAST Study Group.

Authors: 
Journal:  Gut       Date:  1993-12       Impact factor: 23.059

10.  Pathological characteristics of gastric carcinomas in the very old.

Authors:  N Inoshita; A Yanagisawa; T Arai; T Kitagawa; K Hirokawa; Y Kato
Journal:  Jpn J Cancer Res       Date:  1998-10
View more
  114 in total

1.  Mapping analysis of ghrelin producing cells in the human stomach associated with chronic gastritis and early cancers.

Authors:  Shuji Takiguchi; Shinichi Adachi; Kazuyoshi Yamamoto; Eiichi Morii; Hiroshi Miyata; Kiyokazu Nakajima; Makoto Yamasaki; Kenji Kangawa; Masaki Mori; Yuichiro Doki
Journal:  Dig Dis Sci       Date:  2011-12-07       Impact factor: 3.199

2.  Indications for staging laparoscopy in clinical T4M0 gastric cancer.

Authors:  Kazuhito Tsuchida; Takaki Yoshikawa; Akira Tsuburaya; Haruhiko Cho; Osamu Kobayashi
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

3.  The prognostic significance of p53 expression in gastric cancer: a meta-analysis.

Authors:  Kongkong Wei; Lei Jiang; Yaoyao Wei; Yufeng Wang; Xuankun Qian; Qiang Dai; Quanlin Guan
Journal:  J Cancer Res Clin Oncol       Date:  2014-10-15       Impact factor: 4.553

Review 4.  Laparoscopic and robot-assisted gastrectomy for gastric cancer: Current considerations.

Authors:  Stefano Caruso; Alberto Patriti; Franco Roviello; Lorenzo De Franco; Franco Franceschini; Andrea Coratti; Graziano Ceccarelli
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

Review 5.  Clinical proteomics identifies potential biomarkers in Helicobacter pylori for gastrointestinal diseases.

Authors:  Chun-Hao Huang; Shyh-Horng Chiou
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

6.  Gastric cancer-a clinicopathological study in a tertiary care centre of North-eastern India.

Authors:  Arun Kumar Barad; Sanjeet Kumar Mandal; Hiriyur S Harsha; Birkumar M Sharma; Th Sudhirchandra Singh
Journal:  J Gastrointest Oncol       Date:  2014-04

7.  Oridonin induces apoptosis in gastric cancer through Apaf-1, cytochrome c and caspase-3 signaling pathway.

Authors:  Ke-Wang Sun; Ying-Yu Ma; Tian-Pei Guan; Ying-Jie Xia; Chang-Ming Shao; Le-Gao Chen; Ya-Jun Ren; Hai-Bo Yao; Qiong Yang; Xu-Jun He
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

8.  Everolimus for previously treated advanced gastric cancer: results of the randomized, double-blind, phase III GRANITE-1 study.

Authors:  Atsushi Ohtsu; Jaffer A Ajani; Yu-Xian Bai; Yung-Jue Bang; Hyun-Cheol Chung; Hong-Ming Pan; Tarek Sahmoud; Lin Shen; Kun-Huei Yeh; Keisho Chin; Kei Muro; Yeul Hong Kim; David Ferry; Niall C Tebbutt; Salah-Eddin Al-Batran; Heind Smith; Chiara Costantini; Syed Rizvi; David Lebwohl; Eric Van Cutsem
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

9.  Prognostic value of tumor-related molecular expression in gastric carcinoma.

Authors:  Zhong-Sheng Zhao; Yuan-Yu Wang; Zai-Yuan Ye; Hou-Quan Tao
Journal:  Pathol Oncol Res       Date:  2009-03-18       Impact factor: 3.201

Review 10.  Chemotherapy for metastatic gastric cancer: past, present, and future.

Authors:  Atsushi Ohtsu
Journal:  J Gastroenterol       Date:  2008-05-06       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.